Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorena Lorefice

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Neuropsychiatric Disease and Treatment|May 3, 2018
New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumabJessica Frau, Giancarlo Coghe, Lorena Lorefice, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 8, 2017
Rescue therapy with alemtuzumab in multiple sclerosis post-natalizumab puerperium reactivationJessica Frau, Giancarlo Coghe, Giuseppe Fenu, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 20, 2014
Long-term benefits of induction therapy in NMO: a case reportJessica Frau, Giancarlo Coghe, Lorena Lorefice, et al.
Life (Basel, Switzerland)|June 28, 2023
The Role of Microorganisms in the Etiopathogenesis of Demyelinating DiseasesJessica Frau, Giancarlo Coghe, Lorena Lorefice, et al.
International Journal of Women'S Health|February 1, 2023
Impact of Menopause in Patients with Multiple Sclerosis: Current PerspectivesLorena Lorefice, Maurizio Nicola D'Alterio, Davide Firinu, et al.
Inflammation & Allergy Drug Targets|February 1, 2014
Monoclonal antibodies: a target therapy for multiple sclerosisLorena Lorefice, Giuseppe Fenu, Jessica Frau, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 7, 2015
Facial synkinesis as a first symptom of multiple sclerosisPaolo Tacconi, M Teresa Peltz, Lorena Lorefice, et al.
International Journal of Environmental Research and Public Health|December 2, 2020
Does Multiple Sclerosis Differently Impact Physical Activity in Women and Man? A Quantitative Study Based on Wearable AccelerometersMassimiliano Pau, Micaela Porta, Giancarlo Coghe, et al.
Journal of Neurology|March 14, 2019
Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosisJessica Frau, Giancarlo Coghe, Lorena Lorefice, et al.
Frontiers in Genetics|February 16, 2023
Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosisLorena Lorefice, Maristella Pitzalis, Federica Murgia, et al.
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Neuropsychiatric Disease and Treatment|May 3, 2018
New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumabJessica Frau, Giancarlo Coghe, Lorena Lorefice, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 8, 2017
Rescue therapy with alemtuzumab in multiple sclerosis post-natalizumab puerperium reactivationJessica Frau, Giancarlo Coghe, Giuseppe Fenu, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 20, 2014
Long-term benefits of induction therapy in NMO: a case reportJessica Frau, Giancarlo Coghe, Lorena Lorefice, et al.
Life (Basel, Switzerland)|June 28, 2023
The Role of Microorganisms in the Etiopathogenesis of Demyelinating DiseasesJessica Frau, Giancarlo Coghe, Lorena Lorefice, et al.
International Journal of Women'S Health|February 1, 2023
Impact of Menopause in Patients with Multiple Sclerosis: Current PerspectivesLorena Lorefice, Maurizio Nicola D'Alterio, Davide Firinu, et al.
Inflammation & Allergy Drug Targets|February 1, 2014
Monoclonal antibodies: a target therapy for multiple sclerosisLorena Lorefice, Giuseppe Fenu, Jessica Frau, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 7, 2015
Facial synkinesis as a first symptom of multiple sclerosisPaolo Tacconi, M Teresa Peltz, Lorena Lorefice, et al.
International Journal of Environmental Research and Public Health|December 2, 2020
Does Multiple Sclerosis Differently Impact Physical Activity in Women and Man? A Quantitative Study Based on Wearable AccelerometersMassimiliano Pau, Micaela Porta, Giancarlo Coghe, et al.
Journal of Neurology|March 14, 2019
Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosisJessica Frau, Giancarlo Coghe, Lorena Lorefice, et al.
Frontiers in Genetics|February 16, 2023
Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosisLorena Lorefice, Maristella Pitzalis, Federica Murgia, et al.
Pageof 10